rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Mosaic Company (The)

MOS · NYSE

MaterialsAgricultural Chemicals & FertilizersNot moving yet

MOS stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 18.6% below that average now. Agricultural Chemicals & Fertilizers: 10% of its 10 stocks in an uptrend (−10 points in four weeks); Materials: 18% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
10% -10 in 4 wk
Insider buys, 12 months
$17K
Insider sales, 12 months
$1.0M
Officials’ trades on record
83

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
2%26%50%Apr 26Jun 26Jul 26Sep 26Oct 26

Agricultural Chemicals & Fertilizers: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Materials: Few of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$6.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

83 disclosed lines: House 35, Senate 47, executive 1; 14 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k22 May 2026filed 1 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k14 Apr 2026filed 8 May 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k9 Jan 2026filed 13 Feb 2026
Val T. Hoyle House: U.S. House ClerkOR04soldspouse$1k–$15k23 Sep 2025filed 10 Oct 2025
Thomas R. Carper Senate: U.S. Senate eFDSenatorsoldspouse$1k–$15k28 Mar 2024filed 29 Mar 2024
Thomas R. Carper Senate: U.S. Senate eFDSenatorsold part ofspouse$1k–$15k11 Dec 2023filed 3 Jan 2024
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k12 Jul 2023filed 13 Aug 2023
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k29 Jun 2023filed 13 Aug 2023
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k10 Apr 2023filed 19 May 2023
Daniel S. Goldman House: U.S. House ClerkNY10bought$1k–$15k10 Apr 2023filed 19 May 2023
Daniel S. Goldman House: U.S. House ClerkNY10bought$1k–$15k1 Mar 2023filed 17 Apr 2023

Insiders

Buy orders, 12 months1
Sale orders, 12 months1
Buyers · sellers1 · 1
WhoDidSharesTraded
Walter F. Precourt IIISVP - Chief Admin Officersold23,000at $22.1219 Aug 2026filed 21 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Sonya C. Little Company insiderDirector · last 23 Sep 20260 · 0
Walter F. Precourt III Company insiderSVP - Chief Admin Officer · last 19 Aug 20260 · 5
Cheryl K. Beebe Company insiderDirector · last 28 May 20261 · 0
David Thomas Seaton Company insiderDirector · last 28 May 20260 · 0
Emery N. Koenig Company insiderDirector · last 28 May 20265 · 0
Gregory L. Ebel Company insiderDirector · last 28 May 20265 · 0
Gretchen H. Watkins Company insiderDirector · last 28 May 20260 · 0
Joao Roberto Goncalves Teixeira Company insiderDirector · last 28 May 20260 · 0
Jody Lynne Kuzenko Company insiderDirector · last 28 May 20261 · 0
Kathleen M. Shanahan Company insiderDirector · last 28 May 20260 · 0
Kelvin R. Westbrook Company insiderDirector · last 28 May 20261 · 1
Timothy S. Gitzel Company insiderDirector · last 28 May 20261 · 0

Same industry

CF CF Industries HoldingsJust started moving0%
NTR NutrienAbove a falling average+0%
ICL ICL GroupNot moving yet-9%
SMG Scotts Miracle-GroNot moving yet-11%
CBUS CibusNot moving yet-20%
EVGN EvogeneNot moving yet-36%
SNES SenesTechNot moving yet-53%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202515.8%
Operating profit marginFY 2025 · to 31 Dec 20256.8%
Free cash flow marginFY 2025 · to 31 Dec 2025-4.4%
Return on capital employedFY 2025 · to 31 Dec 20254.0%
Cash conversionFY 2025 · to 31 Dec 2025153%
Debt to equityFY 2025 · to 31 Dec 20250.06×
Interest coverFY 2025 · to 31 Dec 20253.40×
Share count trendFY 2025 · to 20 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$276.6M
Free cash flowFY 2025 · to 31 Dec 2025−$534.6M

Analyst forecasts

No analyst forecasts yet.